Table of Content


Introduction
Interleukin 1 (IL1) - Overview
Interleukin 1 (IL1) - Therapeutics Development
Interleukin 1 (IL1) - Therapeutics Assessment
Interleukin 1 (IL1) - Companies Involved in Therapeutics Development
Interleukin 1 (IL1) - Drug Profiles
Interleukin 1 (IL1) - Dormant Products
Interleukin 1 (IL1) - Discontinued Products
Interleukin 1 (IL1) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021


List of Tables


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Indications, 2021 (Contd..1)
Number of Products under Development by Indications, 2021 (Contd..2)
Number of Products under Development by Indications, 2021 (Contd..3)
Number of Products under Development by Indications, 2021 (Contd..4)
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Products under Development by Companies, 2021 (Contd..6)
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by 3SBio Inc, 2021
Pipeline by Akeso Inc, 2021
Pipeline by Bio-Thera Solutions Ltd, 2021
Pipeline by Bioiberica SAU, 2021
Pipeline by Devonian Health Group Inc, 2021
Pipeline by Flame Biosciences Inc, 2021
Pipeline by ImmunoChem Therapeutics LLC, 2021
Pipeline by Immunome Inc, 2021
Pipeline by Johnson & Johnson, 2021
Pipeline by Komipharm International Co Ltd, 2021
Pipeline by Link Health Group, 2021
Pipeline by Mabpharm Ltd, 2021
Pipeline by Medifron DBT Co Ltd, 2021
Pipeline by Moderna Inc, 2021
Pipeline by Novartis AG, 2021
Pipeline by Omnitura Therapeutics Inc, 2021
Pipeline by Opsona Therapeutics Ltd, 2021
Pipeline by Peptinov SAS, 2021
Pipeline by R-Pharm, 2021
Pipeline by Regeneron Pharmaceuticals Inc, 2021
Pipeline by SelectImmune Pharma AB, 2021
Pipeline by Spherium Biomed SL, 2021
Pipeline by Swedish Orphan Biovitrum AB, 2021
Pipeline by Therapicon Srl, 2021
Pipeline by ThioLab LLC, 2021
Pipeline by TWi Biotechnology Inc, 2021
Pipeline by XBiotech Inc, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Dormant Products, 2021 (Contd..2)
Dormant Products, 2021 (Contd..3)
Dormant Products, 2021 (Contd..4)
Dormant Products, 2021 (Contd..5)
Dormant Products, 2021 (Contd..6)
Discontinued Products, 2021
Discontinued Products, 2021 (Contd..1)
Discontinued Products, 2021 (Contd..2)